Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors
Clinical trial NCT07656090 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07656090
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-18
- Primary completion
- 2027-10-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.